In addition, the programmed cell death protein 1 ligand (PD‐L1) is an important factor in tumor microenvironment and is associated with the therapeutic effect of immunotherapy.19 The correlation between PD‐L1 and MSI status was also analyzed in this study. This evidence concerns the gene CD274 and neoplasm.